NCT04384627View on ClinicalTrials.gov

Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

August 20, 2024

Study Completion Date

October 1, 2026

Conditions
Nasopharyngeal CarcinomaInduction ChemotherapyRadiotherapy
Interventions
RADIATION

Delineating the GTV according to the pretreatment or post-IC tumor extension

Delineating the GTV according to the pretreatment or post-IC tumor extension

Trial Locations (2)

Unknown

First People's Hospital of Foshan, Foshan, Foshan

People's Hospital of Zhongshan City, Zhongshan

All Listed Sponsors
collaborator

First People's Hospital of Foshan

OTHER

collaborator

Cancer Research Institute of Zhongshan City

OTHER_GOV

lead

Sun Yat-sen University

OTHER

NCT04384627 - Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy | Biotech Hunter | Biotech Hunter